Menu
Your Cart

COVID-19 rtPCR Test (7日前PCR, Travel to China, 7 Day Before Travel)

You’ve probably heard a lot about coronavirus testing recently. Among nucleic acid tests, the polymerase chain reaction (PCR) method is considered the "gold standard" for the detection of COVID-19 and is characterized by rapid detection, high sensitivity, and specificity.
This service is required by the China government as the first rtPCR test 7 days in advance of the travel date to China. In addition, many countries and regional authorities require a negative rtPCR test result in order to travel to these destinations. Our COVID-19 test reports have been accepted by many countries and regional authorities. For a list, see:
Fast COVID-19 testing turnaround gives you peace of mind

COVID-19 rtPCR + IgM (S)+(N) Test (N蛋白三项, Travel to China, Same Day)

This test is a multiplex test including a COVID-19 rtPCR test and two COVID-19 IgM tests (anti-S protein and anti-N protein, respectively).

This service is the COVID-19 rtPCR+IgM (S)+(N) Test 2 days in advance of the travel date. This test is a multiplex test including: (1) a COVID-19 rtPCR test, (2) a COVID-19 IgM test (targeting S (spike) protein), and (3) a COVID-19 IgM test (targeting N (nucleocapsid) protein). Starting Jan 13, 2022, China government requires every traveler who has only received non-inactivated vaccine (for example, Pfizer or Moderna) or has not received vaccination boarding an airplane to China obtain this test 2 days before the flight.
Fast COVID-19 testing turnaround gives you peace of mind

COVID-19 rtPCR 1+ rtPCR 2 Test (双采双检 Travel to China, Same Day)

This test is a multiplex test including two different COVID-19 rtPCR tests, each from an independent nasopharyngeal swab sample. Starting Jan 13, 2022, China government requires every traveler who has received inactivated vaccine boarding an airplane to China obtain negative reports for two different COVID-19 rtPCR tests 2 days before the flight.

如您已经接种灭活疫苗,在2022年1月13日起,请选择预约此“双采双检 双项rtPCR检测”服务。灭活疫苗包括:中国的国药、科兴新冠疫苗等均为灭活疫苗。
Over 80,000 Clinical Tests Served

School COVID-19 Tests

Schedule a COVID-19 rtPCR testing at your location. We service San Jose and the surrounding San Francisco Bay Area. If you prefer to use our location, we can do that too. Regardless of testing location, results will be sent out within 24 hours. We will work with you to make this process seamless.

Please call us: 1-888-992-7678, or send inquires to our email: support@apostledx.com for details.
Over 80,000 Clinical Tests Served

Corporate COVID-19 Tests

We are passionate about helping our community begin their new "normal" by providing a safe work environment. Schedule a COVID-19 rtPCR testing at your company's location. We service San Jose and the surrounding San Francisco Bay Area. Regardless of testing location, results will be sent out within 24 hours. We will work with you to make this process seamless.

Please call us: 1-888-992-7678, or send inquires to our email: support@apostledx.com for details.
Fast COVID-19 testing turnaround gives you peace of mind

Events COVID-19 Tests

Schedule a COVID-19 rtPCR testing at your event location. We service San Jose and the surrounding San Francisco Bay Area. If you prefer to use our location, we can do that too. Regardless of testing location, results will be sent out within 24 hours. We will work with you to make this process seamless.

Please call us: 1-888-992-7678, or send inquires to our email: support@apostledx.com for details.
Fast COVID-19 testing turnaround gives you peace of mind

Maritime COVID-19 Tests

Schedule a COVID-19 rtPCR testing at your ship's dock. We service San Francisco Bay Area. If you prefer to use our location, we can do that too. Regardless of testing location, results will be sent out within 24 hours. We will work with you to make this process seamless.

Please call us: 1-888-992-7678, or send inquires to our email: support@apostledx.com for details.
Over 80,000 Clinical Tests Served

COVID-19 IgM (S/N) Antibody Test (Not For Travel)

This test utilizes U.S. Food and Drug Administration authorized serology tests to detect SARS-CoV-2 IgM antibody, utilizing S protein (spike protein) and N protein (nucleocapsid protein) as the antigen targets. The FDA issued an emergency use authorization (EUA) for the SARS-CoV-2 IgG/IgM serology test kit utilized in this test.

Nearly all immune-competent individuals will develop an immune response following SARS-CoV-2 infection. Like infections with other pathogens, SARS-CoV-2 infection elicits development of IgM and IgG antibodies. Antibodies in some persons can be detected within the first week of illness onset. In SARS-CoV-2 infections, IgM and IgG antibodies can arise nearly simultaneously in serum within 2 to 3 weeks after illness onset. How long IgM and IgG antibodies remain detectable following infection is not known. It is also important to note that some persons do not develop detectable IgG or IgM antibodies following infection. Thus, the absence of detectable IgM or IgG antibodies does not necessarily rule out that they could have previously been infected.
Fast COVID-19 testing turnaround gives you peace of mind

COVID-19 IgM (N protein) Antibody Test (Not For Travel)

This test utilizes U.S. Food and Drug Administration authorized serology tests to detect SARS-CoV-2 IgM antibody, utilizing N protein (nucleocapsid protein) as the antigen targets. The FDA issued an emergency use authorization (EUA) for the SARS-CoV-2 IgG/IgM serology test kit utilized in this test.
Over 80,000 Clinical Tests Served

COVID-19 Neutralization Antibody Test

This test is a qualitative detection of total neutralizing antibodies to SARS- CoV-2 in human serum and K2-EDTA plasma. Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

This test utilizes a U.S. Food and Drug Administration authorized serology test that detects neutralizing antibodies, which are antibodies that bind to a specific part of a pathogen and have been observed in a laboratory setting to decrease SARS-CoV-2 viral infection of cells. The FDA issued an emergency use authorization (EUA) for the SARS-CoV-2 Neutralization Antibody Detection Kit utilized in this test, which specifically detects this type of antibody.
Fast COVID-19 testing turnaround gives you peace of mind

COVID-19 IgG Antibody Test

This test utilizes a U.S. Food and Drug Administration authorized serology test to detect SARS-CoV-2 IgG antibody.

Nearly all immune-competent individuals will develop an immune response following SARS-CoV-2 infection. Like infections with other pathogens, SARS-CoV-2 infection elicits development of IgM and IgG antibodies. Antibodies in some persons can be detected within the first week of illness onset. In SARS-CoV-2 infections, IgM and IgG antibodies can arise nearly simultaneously in serum within 2 to 3 weeks after illness onset. Although scientists do not know how long antibodies to SARS-CoV-2 can be detected, for most other infections, IgM is most useful for determining recent infection as it usually becomes undetectable weeks to months following infection, while IgG may remain detectable for months or years. It is also important to note that some persons do not develop detectable IgG or IgM antibodies following infection. Thus, the absence of detectable IgM or IgG antibodies does not necessarily rule out that they could have previously been infected. The FDA issued an emergency use authorization (EUA) for the SARS-CoV-2 IgG/IgM serology test kit utilized in this test.
Over 80,000 Clinical Tests Served

COVID-19 Saliva IgG Antibody Test

Discover your immune status to COVID-19 without a blood test. The Amperial® COVID-19 Assay is now available exclusively through Apostle Laboratories as a CLIA Certified Laboratory Developed Test. This assay measures your IgG antibody levels to COVID-19 without the need for blood collection. This revolutionary technology developed at research laboratories at UCLA allows measurement of COVID-19 antibodies in saliva using a simple collection brush you place in your mouth for 2 minutes. The report will contain the absolute level of antibodies present and show how your level compares with that of vaccinated individuals in the population. This can give you peace of mind knowing you have ample quantities of antibody or may indicate it is time for a booster shot.
Fast COVID-19 testing turnaround gives you peace of mind

Gastrointestinal Pathogen Panel (GPP)

Gastroenteritis is the second most common illness after the common cold and a leading cause of death worldwide across all age groups. Globally, diarrhea accounts for approximately 2 million deaths in children under 5 years old per year, or 19% of total child deaths.

The Gastrointestinal Pathogen Panel (GPP) is an FDA 510(K) cleared multiplex assay integrated with multiplex chip code technology. The GPP can simultaneously detect and identify multiple bacteria, viruses, and parasites extracted directly from unpreserved stool samples or stool preserved in Cary-Blair transport medium obtained from individuals with signs and/or symptoms of gastrointestinal infection. The turnaround time of GPP is usually 24-48 hrs after sample receiving, or the same day if it's STAT case. Thereby, the GPP can quickly provide qualitative diarrhea-causing pathogens results to physicians to facilitate the appropriate treatment of patients and reduce the inappropriate use of drugs.
Over 80,000 Clinical Tests Served

Respiratory Pathogen Panel (RPP)

Respiratory tract infections (RTIs) are very common in all age groups. As a large number of pathogens cause respiratory infection including both viruses and bacteria, knowledge of the etiology of an RTI is essential to facilitate the appropriate treatment of patients and reduces the inappropriate use of drugs.

FDA 510(k) Cleared Respiratory Pathogen Panel (RPP) is capable of the simultaneous detection and identification of nucleic acids from multiple viruses and bacteria extracted from nasopharyngeal swab (NPS) samples obtained from individuals with signs and/or symptoms of respiratory tract infection. This fully automated system can process up to 94 patient samples simultaneously. Thereby, RPP can provide appropriate results to physicians within a short turnaround time (24-48 hours after sample receiving, or the same day if it's STAT case. ) to aid RTI pathogen diagnosis.

How It Works

The testing steps are as easy as 1-2-3.

Please follow the steps when placing the order:
1. Place the order online.
2. Pre-register the patients.
3. Drive to our San Jose site, located at 160 E Tasman Dr, STE 116, San Jose, CA 95134, at the reserved date and time. Park in the rear parking lot. A clinical technologist will collect a sample using a nasopharyngeal swab and a blood sample.
We will send you a test report the same night (estimate, actual may vary)!
Please review Terms and Conditions, including Cancellation Policy, Informed Consent.

Location

Client Travel Destinations

Our clients have traveled to a wide range of countries and regions. Our COVID-19 test reports have been accepted by many countries and regional authorities.

Our clients' destinations include: China, USA (domestic flights out of California), Canada, Argentina, Switzerland, Iceland, Italy, Ireland, Japan, Korea, India, Nepal, Singapore, Malaysia, China Taiwan, China Hong Kong, French Polynesia, Turkey, Qatar, Bahrain, Jordan, Israel, Saudi Arabia, Uganda, Tanzania, and so on.

Apostle In Social Media

See how Jerry Kowal (郭杰瑞)did his COVID-19 tests at Apostle Diagnostics.
Media is referenced from Jerry Kowal's social media accounts.

About Us

We are a group of healthcare professionals dedicated to fighting diseases together with our community. We are a CLIA Certified and California State licensed Clinical Laboratory founded in 2017 and located in San Jose, California. Let us know if you have any questions.